Enclomiphene
$89.99
In stockEnclomiphene is a selective estrogen receptor modulator (SERM) studied for its effects on testosterone production and reproductive hormones in men. It is one of the two molecular forms found in clomiphene and works by reducing estrogen’s feedback signal to the brain, encouraging the release of hormones that stimulate testicular function and testosterone production
| SKU | RC-RR-ENCLO-60CT |
|---|---|
| Manufacturer | R+R Innovations |
| Form | Capsule |
| Strength | 12.5mg |
| Size | 60 ct |
| Reported Result | Supplier spec pending verification |
| Stock | In stock |
| Documentation Status | Pending Final COA |
Product Description
Enclomiphene is a selective estrogen receptor modulator (SERM) studied for its effects on testosterone production and reproductive hormones in men. It is one of the two molecular forms found in clomiphene and works by reducing estrogen’s feedback signal to the brain, encouraging the release of hormones that stimulate testicular function.
Unlike testosterone replacement, which supplies testosterone from an outside source, enclomiphene has been investigated for its ability to increase the body’s own production. Clinical research has focused primarily on men with secondary hypogonadism—low testosterone associated with insufficient hormonal signaling to the testes.
What research has shown:
Increased testosterone: Randomized clinical trials found that enclomiphene raised total testosterone into the normal range in studied men with secondary hypogonadism.
Increased LH and FSH: Studies observed increases in luteinizing hormone (LH), which signals testosterone production, and follicle-stimulating hormone (FSH), which supports sperm production.
Maintained sperm concentration: In two 16-week phase III trials involving overweight men with secondary hypogonadism, enclomiphene maintained sperm concentrations within the normal range, while testosterone gel substantially reduced sperm production.
Storage and handling: Keep sealed, dry, and protected from heat and direct light unless the final product label or COA states otherwise. Maintain the product with its matching batch record.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| 2026-02-06 | 99.59% | Feb 17, 2026 | MZ Biolabs | Complete | View COA |
.png)